Medical Disclaimer
Please read this disclaimer carefully before using Path to Peptides.
Not Medical Advice
All content on Path to Peptides — including compound profiles, protocol guides, dosage references, mechanism-of-action descriptions, calculators, and tools — is provided strictly for educational and research purposes. This information is derived from published scientific literature and is intended to support academic understanding of peptide research.
Nothing on this platform should be interpreted as a recommendation to use, purchase, or administer any compound. The inclusion of dosing information from published studies does not constitute a prescription or treatment protocol.
No Doctor-Patient Relationship
Using Path to Peptides does not create a doctor-patient, clinician-client, or any other therapeutic relationship between you and Path to Peptides, its contributors, or its advisory board members. No information on this site is a substitute for a professional medical consultation.
Consult a Healthcare Provider
Always seek the advice of a qualified physician, pharmacist, or other licensed healthcare professional with any questions regarding a medical condition, treatment options, or the use of any compound discussed on this platform. Never disregard professional medical advice or delay seeking it because of information you read on Path to Peptides.
Research Compound Disclaimer
The peptides and research compounds discussed on this platform are presented in the context of published scientific research. Many of these compounds are investigational, not approved for human use by the FDA or equivalent regulatory agencies, or are available only for in-vitro research purposes.
The legal status of research peptides varies significantly by jurisdiction. It is your responsibility to understand and comply with all applicable local, state, national, and international laws regarding the acquisition, possession, and use of any compound referenced on this platform.
Sponsorship Disclosure
BioRoot AI and LiveWell Peptides are paid sponsors of Path to Peptides. These sponsorships do not influence our editorial content, evidence grading, or compound recommendations. All BioRoot AI and LiveWell Peptides links on this site carry rel="sponsored" attributes and are clearly labeled as sponsored placements.
Third-Party Links
Path to Peptides contains links to external websites, including research peptide vendors and third-party tools such as BioRoot AI and LiveWell Peptides (Official Sponsors). These links are provided for informational convenience only.
Path to Peptides does not endorse, guarantee, or assume responsibility for the accuracy, safety, legality, or quality of any products, services, or content available through external websites. Your interactions with third-party sites are governed by those sites' own terms of service and privacy policies.
No Guarantees
Results, outcomes, and effects described in the scientific literature referenced on this platform may not be replicable in all settings and may not apply to any individual. Research findings reflect controlled experimental conditions and specific study populations. Individual responses to any compound may vary significantly based on genetics, health status, concurrent medications, and other factors.
Path to Peptides makes no warranties or representations regarding the completeness, accuracy, or applicability of any information presented.
Assumption of Risk
By using Path to Peptides, you acknowledge and agree that you assume all risk associated with any decisions you make based on information found on this platform. Path to Peptides, its contributors, advisory board members, and affiliated parties shall not be held liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of this website or your reliance on any information provided herein.
You are solely responsible for evaluating the accuracy, completeness, and usefulness of any information, opinion, or content available through this platform.
This disclaimer may be updated periodically. Continued use of Path to Peptides following any changes constitutes acceptance of those changes.